Clavudale 40 mg / 10 mg Tablets for Cats and Dogs

País: Regne Unit

Idioma: anglès

Font: VMD (Veterinary Medicines Directorate)

Compra'l ara

Fitxa tècnica Fitxa tècnica (SPC)
04-01-2023

ingredients actius:

Amoxicillin, Clavulanic Acid

Disponible des:

Dechra Limited

Codi ATC:

QJ01CR02

Designació comuna internacional (DCI):

Amoxicillin, Clavulanic Acid

formulario farmacéutico:

Tablet

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cats, Dogs

Área terapéutica:

Antimicrobial

Estat d'Autorització:

Authorized

Data d'autorització:

2010-01-08

Fitxa tècnica

                                Revised: October 2020
AN: 00314/2020
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Clavudale 40 mg/10 mg tablets for cats and dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 tablet contains:
Active substances:
Amoxicillin (as amoxicillin trihydrate)
40 mg
Clavulanic acid (as potassium clavulanate)
10 mg
Excipient:
Erythrosine (E127)
0.75 mg
For the full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Pink, oblong, scored, meat flavoured tablets.
The tablet can be divided into halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of bacterial infections susceptible to amoxicillin
in combination with
clavulanic acid where clinical experience and/or sensitivity testing
indicates the
product as the drug of choice.
Uses include:
Skin infections (including deep and superficial pyodermas) associated
with
Staphylococcus spp. and Streptococcus spp.;
Infections of the oral cavity (mucous membrane) associated with
Clostridium spp.,
Corynebacterium spp., Staphylococcus spp., Streptococcus spp.,
Bacteroides spp.
and Pasteurella spp.;
Urinary tract infections associated with Staphylococcus spp.,
Streptococcus spp.,
Escherichia coli and Proteus mirabilis;
Respiratory tract infections associated with Staphylococcus spp.,
Streptococcus
spp., and Pasteurella spp.
Gastrointestinal infections associated with Escherichia coli and
Proteus mirabilis.
Revised: October 2020
AN: 00314/2020
Page 2 of 6
4.3
CONTRAINDICATIONS
Do not use in rabbits, guinea pigs, hamsters and gerbils.
Do not use in animals with known hypersensitivity to penicillin or
substances of the β-
lactam group or any of the excipients.
Do not use in animals with either oliguria or anuria associated with
renal dysfunction.
Do not use in cases of known resistance to the combination of
amoxicillin and
clavulanic acid.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautio
                                
                                Llegiu el document complet
                                
                            

Cerqueu alertes relacionades amb aquest producte